Cargando…

Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon

Background and Objectives: We have recently reported that stains have calcium channel blocking activity in isolated jejunal preparations. In this study, we examined the effects of atorvastatin and fluvastatin on blood vessels for a possible vasorelaxant effect. We also studied the possible additiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Niaz, Ali, Wajid, Ullah, Abid, Ahmad, Shujaat, Alsaiari, Ahad Amer, Almehmadi, Mazen, Abdulaziz, Osama, Allahyani, Mamdouh, Aljuaid, Abdulelah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303907/
https://www.ncbi.nlm.nih.gov/pubmed/37374229
http://dx.doi.org/10.3390/medicina59061023
_version_ 1785065386227531776
author Ali, Niaz
Ali, Wajid
Ullah, Abid
Ahmad, Shujaat
Alsaiari, Ahad Amer
Almehmadi, Mazen
Abdulaziz, Osama
Allahyani, Mamdouh
Aljuaid, Abdulelah
author_facet Ali, Niaz
Ali, Wajid
Ullah, Abid
Ahmad, Shujaat
Alsaiari, Ahad Amer
Almehmadi, Mazen
Abdulaziz, Osama
Allahyani, Mamdouh
Aljuaid, Abdulelah
author_sort Ali, Niaz
collection PubMed
description Background and Objectives: We have recently reported that stains have calcium channel blocking activity in isolated jejunal preparations. In this study, we examined the effects of atorvastatin and fluvastatin on blood vessels for a possible vasorelaxant effect. We also studied the possible additional vasorelaxant effect of atorvastatin and fluvastatin, in the presence of amlodipine, to quantify its effects on the systolic blood pressure of experimental animals. Materials and Methods: Atorvastatin and fluvastatin were tested in isolated rabbits’ aortic strip preparations using 80mM Potassium Chloride (KCl) induced contractions and 1 micro molar Norepinephrine (NE) induced contractions. A positive relaxing effect on 80 mM KCl induced contractions were further confirmed in the absence and presence of atorvastatin and fluvastatin by constructing calcium concentration response curves (CCRCs) while using verapamil as a standard calcium channel blocker. In another series of experiments, hypertension was induced in Wistar rats and different test concentrations of atorvastatin and fluvastatin were administered in their respective EC(50) values to the test animals. A fall in their systolic blood pressure was noted using amlodipine as a standard vasorelaxant drug. Results: The results show that fluvastatin is more potent than amlodipine as it relaxed NE induced contractions where the amplitude reached 10% of its control in denuded aortae. Atorvastatin relaxed KCL induced contractions with an amplitude reaching 34.4% of control response as compared to the amlodipine response, i.e., 39.1%. A right shift in the EC(50) (Log Ca++ M) of Calcium Concentration Response Curves (CCRCs) implies that statins have calcium channel blocking activity. A right shift in the EC(50) of fluvastatin with relatively less EC(50) value (−2.8 Log Ca++ M) in the presence of test concentration (1.2 × 10(−7) M) of fluvastatin implies that fluvastatin is more potent than atorvastatin. The shift in EC(50) resembles the shift of Verapamil, a standard calcium channel blocker (−1.41 Log Ca++ M). Conclusions: Atorvastatin and fluvastatin relax the aortic strip preparations predominantly through the inhibition of voltage gated calcium channels in high molar KCL induced contractions. These statins also inhibit the effects of NE induced contractions. The study also confirms that atorvastatin and fluvastatin potentiate blood pressure lowering effects in hypertensive rats.
format Online
Article
Text
id pubmed-10303907
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103039072023-06-29 Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon Ali, Niaz Ali, Wajid Ullah, Abid Ahmad, Shujaat Alsaiari, Ahad Amer Almehmadi, Mazen Abdulaziz, Osama Allahyani, Mamdouh Aljuaid, Abdulelah Medicina (Kaunas) Article Background and Objectives: We have recently reported that stains have calcium channel blocking activity in isolated jejunal preparations. In this study, we examined the effects of atorvastatin and fluvastatin on blood vessels for a possible vasorelaxant effect. We also studied the possible additional vasorelaxant effect of atorvastatin and fluvastatin, in the presence of amlodipine, to quantify its effects on the systolic blood pressure of experimental animals. Materials and Methods: Atorvastatin and fluvastatin were tested in isolated rabbits’ aortic strip preparations using 80mM Potassium Chloride (KCl) induced contractions and 1 micro molar Norepinephrine (NE) induced contractions. A positive relaxing effect on 80 mM KCl induced contractions were further confirmed in the absence and presence of atorvastatin and fluvastatin by constructing calcium concentration response curves (CCRCs) while using verapamil as a standard calcium channel blocker. In another series of experiments, hypertension was induced in Wistar rats and different test concentrations of atorvastatin and fluvastatin were administered in their respective EC(50) values to the test animals. A fall in their systolic blood pressure was noted using amlodipine as a standard vasorelaxant drug. Results: The results show that fluvastatin is more potent than amlodipine as it relaxed NE induced contractions where the amplitude reached 10% of its control in denuded aortae. Atorvastatin relaxed KCL induced contractions with an amplitude reaching 34.4% of control response as compared to the amlodipine response, i.e., 39.1%. A right shift in the EC(50) (Log Ca++ M) of Calcium Concentration Response Curves (CCRCs) implies that statins have calcium channel blocking activity. A right shift in the EC(50) of fluvastatin with relatively less EC(50) value (−2.8 Log Ca++ M) in the presence of test concentration (1.2 × 10(−7) M) of fluvastatin implies that fluvastatin is more potent than atorvastatin. The shift in EC(50) resembles the shift of Verapamil, a standard calcium channel blocker (−1.41 Log Ca++ M). Conclusions: Atorvastatin and fluvastatin relax the aortic strip preparations predominantly through the inhibition of voltage gated calcium channels in high molar KCL induced contractions. These statins also inhibit the effects of NE induced contractions. The study also confirms that atorvastatin and fluvastatin potentiate blood pressure lowering effects in hypertensive rats. MDPI 2023-05-25 /pmc/articles/PMC10303907/ /pubmed/37374229 http://dx.doi.org/10.3390/medicina59061023 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ali, Niaz
Ali, Wajid
Ullah, Abid
Ahmad, Shujaat
Alsaiari, Ahad Amer
Almehmadi, Mazen
Abdulaziz, Osama
Allahyani, Mamdouh
Aljuaid, Abdulelah
Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon
title Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon
title_full Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon
title_fullStr Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon
title_full_unstemmed Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon
title_short Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon
title_sort atorvastatin and fluvastatin potentiate blood pressure lowering effect of amlodipine through vasorelaxant phenomenon
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303907/
https://www.ncbi.nlm.nih.gov/pubmed/37374229
http://dx.doi.org/10.3390/medicina59061023
work_keys_str_mv AT aliniaz atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon
AT aliwajid atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon
AT ullahabid atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon
AT ahmadshujaat atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon
AT alsaiariahadamer atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon
AT almehmadimazen atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon
AT abdulazizosama atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon
AT allahyanimamdouh atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon
AT aljuaidabdulelah atorvastatinandfluvastatinpotentiatebloodpressureloweringeffectofamlodipinethroughvasorelaxantphenomenon